Immunohistochemistry applied to the differential diagnosis between ductal and lobular carcinoma of the breast.

Autor: de Deus Moura R; Consultoria em Patologia, Botucatu, SP 18602-010, Brazil., Wludarski SC, Carvalho FM, Bacchi CE
Jazyk: angličtina
Zdroj: Applied immunohistochemistry & molecular morphology : AIMM [Appl Immunohistochem Mol Morphol] 2013 Jan; Vol. 21 (1), pp. 1-12.
DOI: 10.1097/PAI.0b013e318255bafa
Abstrakt: The distinction between classic lobular and ductal carcinoma, both in situ and invasive, has important therapeutic and management implications. Most ductal and lobular carcinomas are distinguished readily on hematoxylin-eosin-stained sections because of distinct histomorphologic features. In cases with ambiguous morphologic features, however, categorization in one or another type can be a challenge. Several immunohistochemical markers, including epithelial cadherin, p120, β-catenin, and low-molecular-weight and high-molecular-weight cytokeratins among others, have been introduced to help better discriminate between lobular neoplasia and ductal carcinoma. In this critical review of the literature, we comment about the usefulness and the limitations of these markers to improve the accuracy in the differential diagnosis of breast pathology.
Databáze: MEDLINE